Skip to content
This website is intended for US healthcare professionals only.
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
HAE Overview
HAE Video Library
Netherton Syndrome (NS)
Complement-Mediated Diseases
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
HAE Overview
HAE Video Library
Netherton Syndrome (NS)
Complement-Mediated Diseases
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Hereditary Angioedema Patients Would Prefer Newer-Generation Oral Prophylaxis
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Managing Diagnosis, Treatment and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Optimal Management of Hereditary Angioedema: Shared Decision-Making
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Meeting Patient Needs in Hereditary Angioedema Care
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Once-daily oral berotralstat for long-term prophylaxis of hereditary angioedema: The open-label extension of the APeX-2 randomized trial
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Previous Page
1
2
3
4
5
Next Page
